1. Zulresso is the first treatment specifically intended for women with postpartum depression. Administered intravenously, the drug is designed to work faster than other antidepressants.
2. Optimizer Smart system is a device for treating chronic, moderate-to-severe heart failure who are not able to receive cardiac resynchronization therapy.
3. Sunosi was approved to treat excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea.
4. Trecentriq received another approval from the FDA. It is now approved to treat extensive-stage small cell lung cancer. Tricentriq was previously approved to treat breast cancer.
More articles on supply chain:
Supplies of bladder cancer drug are dwindling
Washington faces critically low blood supply
Supply chain savings tip of the week: Manage your total transportation spend
